Skip to main content

An Open-Label Extension Study of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis ELEVATE UC OLE: An Open-Label Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

Arena Pharmaceuticals, Inc.

Start Date

October 7, 2020

End Date

September 30, 2024
 

Administered By

Medicine, Gastroenterology

Awarded By

Arena Pharmaceuticals, Inc.

Start Date

October 7, 2020

End Date

September 30, 2024